Methylation Support Complex.

5-methyltetrahydrofolate is the methyl donor that methionine synthase transfers to homocysteine. A methylation complex that supplies folate in the 5-MTHF form skips the dihydrofolate reductase and MTHFR steps that reduced and unmethylated folates must pass through. Without adequate reduced folate the rest of the cycle stalls regardless of how much cobalamin is present.

Methionine synthase carries a cobalamin cofactor that shuttles the methyl group from 5-MTHF to homocysteine. When cobalamin is short, folate accumulates in the methylated form and cannot re-enter the cycle, the classic methyl-folate trap described in standard biochemistry. Pairing the two is why methylation formulas carry both rather than either alone.

Pyridoxal-5-phosphate is the cofactor for cystathionine beta-synthase and cystathionine gamma-lyase, the two transsulfuration enzymes that route homocysteine toward cysteine instead of back to methionine. It is also the cofactor for serine hydroxymethyltransferase, which loads one-carbon units onto tetrahydrofolate. B6 status therefore sets how much of the pathway runs as disposal rather than recycling.

MTHFR is a flavoprotein and holds FAD, which riboflavin supplies. Low riboflavin status reduces the stability of the enzyme, an effect most discussed in people carrying the thermolabile MTHFR variant. Formulators include riboflavin so the folate reduction step is not cofactor-limited.

Betaine-homocysteine methyltransferase remethylates homocysteine using betaine as the methyl donor, a route that runs in liver and kidney independently of folate and cobalamin. It gives the cycle a second lane when the folate lane is loaded. The two routes converge on the same product, methionine.

Choline is oxidised to betaine in the mitochondria of liver and kidney, which is where most endogenous betaine comes from. Dietary choline and folate spare one another, since a low folate supply pushes more choline down the oxidation route and leaves less for phosphatidylcholine synthesis. A methylation complex that includes choline supports both demands at once.

Glycine N-methyltransferase consumes surplus S-adenosylmethionine by methylating glycine to sarcosine, which is the main buffer against an oversupply of methyl groups. Glycine availability therefore influences how tightly the SAM to SAH ratio is held. It is a regulator of the cycle rather than an input to it.

Serine hydroxymethyltransferase moves a one-carbon unit from serine onto tetrahydrofolate, producing glycine and 5,10-methylene-THF. That reaction is the dominant entry point for one-carbon units into the folate pool. Serine supply is upstream of everything a methyl donor complex does.

S-adenosylmethionine is the product the whole cycle exists to make, the universal methyl donor for more than a hundred methyltransferases. Supplying it directly and supplying its precursors act on the same node from opposite ends. Taken together the two overlap, so co-dosing is a formulation decision rather than an additive gain.

Guanidinoacetate N-methyltransferase, the final step of endogenous creatine synthesis, is one of the largest single consumers of SAM-derived methyl groups in the body. Supplemental creatine reduces the need for that synthesis and therefore lowers demand on the methyl pool. The relationship is a sparing effect on the donor supply, not an effect on the methylation enzymes themselves.

Nicotinamide N-methyltransferase disposes of excess nicotinamide by methylating it with SAM, and the methylated product is excreted. Large niacinamide intakes therefore draw on the same methyl pool a methylation complex is trying to fill. Anyone stacking high-dose nicotinamide alongside methyl donors is running two demands on one supply.

Betaine-homocysteine methyltransferase and methionine synthase both carry catalytic zinc that activates the thiol of homocysteine for methyl transfer. Zinc status therefore sits underneath both remethylation routes. It is a structural cofactor rather than a substrate.

Transsulfuration converts homocysteine through cystathionine to cysteine, which is the rate-limiting substrate for glutathione synthesis. N-acetylcysteine feeds that same cysteine pool from outside the cycle. The two arrive at the same downstream node by different routes.

Methionine adenosyltransferase requires magnesium and ATP to convert methionine into S-adenosylmethionine. Every methyl transfer downstream depends on that one activation step. Magnesium is a background requirement rather than a targeted pairing.

Folic acid is the fully oxidised synthetic form and must be reduced by dihydrofolate reductase before it can join the folate pool. Unmetabolised folic acid and 5-MTHF share the same cellular folate transporters, so large folic acid intakes can compete with the methylated form. Formulas generally carry one or the other rather than both.

Methionine is the amino acid the cycle regenerates and the direct substrate for SAM synthesis. Adding it raises flux into the cycle and also raises homocysteine generated on the far side of each methyl transfer. Whether that is useful depends on whether the remethylation and transsulfuration cofactors are in place.

Sulfite oxidase is a molybdenum enzyme and handles the sulfite generated as cysteine is catabolised at the end of the transsulfuration arm. A heavy methyl-donor and sulfur amino acid load increases traffic through that terminal step. The pairing is about clearing the pathway's end product rather than driving methylation itself.